Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

NewSelf vs NoBsRx

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
NewSelf logo

NewSelf

8.3
★★★★4.2/5

Best for: lowest-cost compounded GLP-1 with pharmacy quality transparency

Visit NewSelf
VS

NoBsRx

7.6
★★★3.8/5

Best for: fully published, flat-dose compounded GLP-1 pricing with the dispensing pharmacies named

Visit NoBsRx

NewSelf and NoBsRx are both GLP-1 Providers competing for the same patients, but they make different trade-offs on price, coverage, and what's included. In our scoring, NewSelf starts lower at $100/mo versus $140/mo, and NewSelf edges ahead overall (8.3 vs 7.6 out of 10). Below we break down pricing, what each plan covers, the six-dimension score, pros and cons, and exactly who should pick which.

Pricing

NewSelf

Semaglutide+ (best price)Compounded
$100/mo
semaglutide

All dosages same price

Semaglutide+ (regular)Compounded
$135/mo
semaglutide
Tirzepatide+ (best price)Compounded
$144/mo
tirzepatide

All dosages same price

Tirzepatide+ (regular)Compounded
$225/mo
tirzepatide

NoBsRx

Standard injectable program, monthly plan (28-day billing cycle)Compounded
$179/mo
semaglutide

Pricing page: '$179/ monthly', flagged 'Popular'. Prepaid terms: 12 weeks $499, 24 weeks $999, 52 weeks $1,899. 'No dose-based price changes'.

Standard oral program, monthly plan (28-day billing cycle)Compounded
$199/mo
semaglutide

Pricing page: '$199/ monthly'. Prepaid terms: 12 weeks $579, 24 weeks $1,149, 52 weeks $2,199. Oral dosage form not specified.

Standard injectable program, monthly plan (28-day billing cycle)Compounded
$249/mo
tirzepatide

Pricing page: '$249/ monthly'. Prepaid terms: 12 weeks $649, 24 weeks $1,289, 52 weeks $2,599. 'No dose-based price changes'.

Low-dose injectable program, monthly plan (28-day billing cycle)Compounded
$140/mo
semaglutide

Pricing page 'Low-dose injectable semaglutide program': '$140/ monthly'; 12 weeks $409.

Low-dose oral program, monthly plan (28-day billing cycle)Compounded
$179/mo
semaglutide

Pricing page 'Low-dose oral semaglutide program': '$179/ monthly'; 12 weeks $409.

Low-dose injectable program, monthly plan (28-day billing cycle)Compounded
$140/mo
tirzepatide

Pricing page 'Low-dose injectable tirzepatide program': '$140/ monthly'; 12 weeks $409.

Get alerted when GLP-1 prices drop

Join the GLP-1 price-watch list — we re-verify 500+ providers' prices on their own sites and email you when tracked prices move.

What’s included

NewSelf

What the monthly price covers

Medication

Included

Provider visits

Included

Shipping

Included

Lab work

Not disclosed

Coaching

Not disclosed

NoBsRx

Inclusions not disclosed.

Score breakdown

Both providers are scored on the same six-dimension framework. The gradient bar marks the stronger side on each dimension.

NewSelf

8.3/10

Overall

NoBsRx

7.6/10

Value25%

9.0A
vs
B
8.0

Effectiveness25%

8.0A
vs
B
8.0

User Experience15%

8.0A
vs
B
7.5

Trust & Safety15%

8.3A
vs
B
6.8

Accessibility10%

8.5A
vs
B
7.0

Support10%

7.9A
vs
B
7.3

Features & Coverage

FeatureNewSelfNoBsRx
Starting Price$100/mo$140/mo
Features6 features8 features
States Available49Not disclosed
Compounded✓ Yes✓ Yes
Brand Name
FSA/HSA Accepted
FDA Warnings1 warningNone

About NewSelf

NewSelf offers compounded semaglutide+ (with B12/Glycine, from $99.97/mo) and compounded tirzepatide+ (with B6/Glycine, from $144.49/mo). LegitScript certified. Available in 48 states + Puerto Rico. Uses 503A licensed pharmacies with third-party testing.

Read our full NewSelf review →

About NoBsRx

NoBsRx is a telehealth platform that connects you with licensed providers for compounded GLP-1 treatment, filled by state-licensed 503A pharmacies it names in its terms. Every program price is posted before you start: injectable semaglutide $179/mo, oral semaglutide $199/mo and injectable tirzepatide $249/mo, with low-dose programs from $140/mo and no price change as your dose rises. Prepaid 12-, 24- and 52-week terms cost less per month.

Read our full NoBsRx review →

Pros & Cons

NewSelf

What we like

  • Semaglutide+ from $99.97/mo — among the lowest prices in the dataset
  • All dosages at the same price — no price escalation as dose increases
  • LegitScript certified with 503A licensed pharmacies
  • Third-party potency, sterility, and endotoxicity testing
  • 48 states + Puerto Rico coverage
  • B12/B6 + Glycine enhanced formulations
  • No membership fees

Watch-outs

  • Not available in Mississippi and Louisiana
  • Compounded only — no brand-name options
  • Site also promotes AI health optimization and longevity (broader platform)

NoBsRx

What we like

  • Every program price is posted before intake with no email wall: semaglutide from $179/mo, tirzepatide $249/mo
  • Same price at every dose: each program card reads 'No dose-based price changes'
  • Low-dose injectable semaglutide or tirzepatide at $140/mo, plus an oral semaglutide option
  • Its terms name the four state-licensed pharmacies that may fill your prescription, with addresses and phone numbers
  • LegitScript seal is served from LegitScript's own image server, not self-hosted
  • Publishes a support phone number and email, with email replies promised within 1–2 business days
  • States plainly that its compounded semaglutide and tirzepatide are not FDA-approved

Watch-outs

  • No company legal name, business address or governing state is published anywhere on the site
  • The prescribing medical group is not named; the site says only that independent licensed providers review your intake
  • Plans are labeled monthly, but the intake's cancellation policy says charges run every 28 days: 13 charges a year, not 12
  • Its subscription terms say medication, dispensing and shipping fees are outside the platform fee, at odds with 'what's published is what you pay'
  • Cancellation instructions conflict: NoBsRx says email support (no self-service), the intake's policy says use the patient portal
  • Platform fees are non-refundable once a clinical review starts, even if you are found ineligible
  • State availability is not published; the site says programs are not available in all states
  • Compounded semaglutide and tirzepatide are not FDA-approved

Our Verdict

Winner: NewSelf

NewSelf edges out NoBsRx with a higher overall score of 8.3/10 and is particularly strong for lowest-cost compounded GLP-1 with pharmacy quality transparency. NoBsRx remains a solid alternative, especially if you're looking for fully published, flat-dose compounded GLP-1 pricing with the dispensing pharmacies named.

Choose NewSelf if…

You want lowest-cost compounded GLP-1 with pharmacy quality transparency and a starting price around $100/mo.

Choose NoBsRx if…

You want fully published, flat-dose compounded GLP-1 pricing with the dispensing pharmacies named and a starting price around $140/mo.

Ready to start? Vetted GLP-1 providers

Vetted telehealth providers that prescribe GLP-1 online.

No insurance needed · vetted by our editors

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.6

Sprout Health

LegitScript-verified compounded GLP-1 via named pharmacies

7.9

Trimi Health

Budget-conscious shoppers

8.0

ShedRx

Mainstream telehealth GLP-1 access

NewSelf vs NoBsRx: FAQ

NewSelf is cheaper. Its lowest ongoing monthly cash price is $100/mo, compared with $140/mo for NoBsRx. We compare standing (not first-month promo) prices so the figures reflect what you'd actually pay month to month.
NewSelf scores higher overall at 8.3/10 versus 7.6/10, and is particularly strong for lowest-cost compounded GLP-1 with pharmacy quality transparency. That said, NoBsRx is a better fit if you want fully published, flat-dose compounded GLP-1 pricing with the dispensing pharmacies named.
NewSelf lists availability in 49 states, while NoBsRx's state list is not publicly listed.
Neither NewSelf nor NoBsRx is currently an affiliate partner, so we earn no commission from either. We rank all providers editorially using the same six-dimension framework and disclose any commercial relationships.
For Semaglutide, NewSelf is cheaper at $100/mo versus $140/mo at NoBsRx.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Continue exploring NewSelf and NoBsRx head-to-heads in the same category.

Or see the full category ranking.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.